MedPath

TALIAZ LTD

🇮🇱Israel
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:0

Trial Phases

2 Phases

Phase 4:1
Not Applicable:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Not Applicable
2 (66.7%)
Phase 4
1 (33.3%)

Confirm the Effectiveness of Predictix Genetics Antidepressant -Guided Treatment in Adults With MDD

Not Applicable
Recruiting
Conditions
Major Depressive Disorder
First Posted Date
2021-11-30
Last Posted Date
2021-11-30
Lead Sponsor
Taliaz Ltd.
Target Recruit Count
354
Registration Number
NCT05137197
Locations
🇧🇪

Psy Pluriel, Liège, Belgium

🇫🇷

Hospital Pitié Salpétrière, Paris, France

🇨🇭

Hôpitaux Universitaires de Genève, Geneve, Switzerland

Post Marketing Study for the Evaluation of Predictix Antidepressant Clinician Software Support Tool in Prescribing Antidepressant Medication/s for the Treatment of Patients Suffering From Major Depressive Disorder

Phase 4
Conditions
Major Depressive Disorder
First Posted Date
2019-10-24
Last Posted Date
2019-10-24
Lead Sponsor
Taliaz Ltd.
Target Recruit Count
30
Registration Number
NCT04138290
Locations
🇫🇷

Hospital Pitié Salpétrière, Paris, France

Controlled Study to Evaluate the Safety and Efficacy of the Predictix Antidepressant Clinician Support Tool

Not Applicable
Conditions
Major Depressive Disorder
First Posted Date
2019-07-24
Last Posted Date
2019-07-24
Lead Sponsor
Taliaz Ltd.
Target Recruit Count
220
Registration Number
NCT04031157
Locations
🇮🇱

Maccabi healthcare services, Tel Aviv, Israel

News

No news found
© Copyright 2025. All Rights Reserved by MedPath